Development of a New Rapid Diagnostic Test to Support Onchocerciasis Elimination
Conditions: Onchocerciasis; Loiasis; Mansonelliasis; Healthy Volunteers Interventions: Biological: Biological samples collection (blood drawing + feces) Sponsors: Bioaster Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials

Safety and Efficacy of Novel Combination Regimens for Treatment of Onchocerciasis
Conditions: Onchocercal Subcutaneous Nodule; Onchocerciasis; Onchocerciasis, Ocular; Onchocerca Infection; Tropical Disease Interventions: Drug: IVM w/ ALB; Drug: IDA; Drug: Mox w/ ALB; Drug: MoxDA Sponsors: Washington University School of Medicine; National Public Health Institute of Liberia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 6, 2023 Category: Research Source Type: clinical trials

Onchocerciasis-Associated Epilepsy, an Explorative Case-control Study
Conditions:   Onchocercal Subcutaneous Nodule;   Epilepsy;   Virus Intervention:   Procedure: nodulectomy Sponsors:   Universiteit Antwerpen;   Amref Health Africa Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 22, 2023 Category: Research Source Type: clinical trials

Effect of Onchocerciasis Elimination Measures on the Incidence of Epilepsy in Maridi, South Sudan
Conditions:   Onchocerciasis;   Epilepsy Intervention:   Drug: bi-annual CDTI Sponsors:   Universiteit Antwerpen;   Amref Health Africa Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2023 Category: Research Source Type: clinical trials

Impact of a Bi-annual CDTI on the Incidence of Epilepsy in an Onchocerciasis-endemic Area
Conditions:   Onchocerciasis;   Epilepsy Intervention:   Drug: Bi-annual CDTI Sponsor:   Universiteit Antwerpen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2023 Category: Research Source Type: clinical trials

Effect of Onchocerciasis Elimination Measures on the Incidence of Epilepsy in Maridi, South Sudan
Conditions:   Onchocerciasis;   Epilepsy Intervention:   Drug: bi-annual CDTI Sponsors:   Universiteit Antwerpen;   Amref Health Africa Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2023 Category: Research Source Type: clinical trials